Skinvisible, Inc.

$0.17-42.97%($-0.13)
TickerSpark Score
32/100
Poor
47
Valuation
30
Profitability
15
Growth
36
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SKVI research report →

52-Week Range11% of range
Low $0.08
Current $0.17
High $0.90

Companywww.skinvisible.com

Skinvisible, Inc. , together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets.

CEO
Terry H. Howlett
IPO
1999
Employees
2
HQ
Las Vegas, NV, US

Price Chart

-18.76% · this period
$0.65$0.39$0.13May 19Nov 17May 19

Valuation

Market Cap
$924.60K
P/E
-0.88
P/S
46.23
P/B
-0.09
EV/EBITDA
-14.53
Div Yield
0.00%

Profitability

Gross Margin
-26.23%
Op Margin
-2412.01%
Net Margin
-5251.06%
ROE
0.00%
ROIC
10.04%

Growth & Income

Revenue
$20.00K · 0.00%
Net Income
$-1,064,034 · -88.11%
EPS
$-0.20 · -81.82%
Op Income
$-496,315
FCF YoY
-48588171.01%

Performance & Tape

52W High
$0.90
52W Low
$0.08
50D MA
$0.26
200D MA
$0.32
Beta
1.84
Avg Volume
528

Get TickerSpark's AI analysis on SKVI

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jan 31, 23MCMORRAN DOREENother12,562,975
Jan 31, 23MCMORRAN DOREENother25,125,950
Jan 31, 23HOWLETT TERRYother14,299,035
Jan 31, 23HOWLETT TERRYother28,598,070
Jun 30, 19MCMORRAN DOREENother5,144,755
Jun 30, 19MCMORRAN DOREENother10,289,510
Jun 30, 19HOWLETT TERRYother5,443,268
Jun 30, 19HOWLETT TERRYother10,886,535
Mar 28, 18MCMORRAN DOREENsell1
Dec 31, 18MCMORRAN DOREENother1

Our SKVI Coverage

We haven't published any research on SKVI yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate SKVI Report →

Similar Companies